Reproductive and hormonal factors and risk of incident rosacea among US White women - 24/07/21
Doi : 10.1016/j.jaad.2021.06.865
Wen-Hui Wu, MS a, Hao Geng, MS b, Eunyoung Cho, ScD b, c, d, A. Heather Eliassen, ScD d, e, Aaron M. Drucker, MD b, f, g, Tricia Y. Li, MD b, Abrar A. Qureshi, MD, MPH b, c, d, Wen-Qing Li, PhD a, b, c, ⁎ 
a Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China
b Department of Dermatology, Warren Alpert Medical School, Brown University, Providence, Rhode Island
c Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island
d Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
e Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
f Department of Medicine, University of Toronto, Toronto, Canada
g Women's College Research Institute, Women's College Hospital, Toronto, Canada
∗Corresponding to: Wen-Qing Li, PhD, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, 52 Fucheng Rd, Haidian District, Beijing, People's Republic of ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)Department of Cancer EpidemiologyPeking University Cancer Hospital & Institute52 Fucheng Rd, Haidian DistrictBeijingPeople's Republic of China
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 24 July 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Key words : hormonal factors, menstrual factors, reproductive factors, rosacea
| Authors Wu and Geng contributed equally to this work. |
|
| Funding sources: Supported by the National Institutes of Health grants for Nurses' Health Study II (U01 CA176726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
|
| IRB approval status: The study was approved by the institutional review board of Brigham and Women’s Hospital and Harvard School of Public Health (Boston, MA). |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?